Cancer Research Network, Inc.
Plantation, Florida 33324
0 studies enrolling now · 10 studies all time
What they study most
Breast Cancer, Breast Neoplasms, Carcinoma, Metastatic Breast, Fatigue, Metastatic Breast Cancer, Neoplasms, Osteoporosis
Studies at this site
- Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2 — Completed
- Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women — Completed
- Zoledronic Acid - Letrozole Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal Therapy — Completed
- Letrozole in Treating Postmenopausal Women With Metastatic Breast Cancer — Completed
- A Study of Weekly Taxotere and Xeloda in Metastatic Breast Cancer — Completed
- An Observational Study of Current Practice Pattern on the Treatment of Women With Metastatic Breast Cancer Whose Tumors Overexpress Her2neu — Completed
- Safety And Efficacy Study Of The Combination Of CpG 7909 And Herceptin In Patients With Metastatic Breast Cancer — Completed
- Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen — Completed
- Docetaxel, Carboplatin, and Capecitabine as Treatment for Patients With Locally Advanced or Inflammatory Breast Cancer Before Surgery — Status unconfirmed
- D-MPH in the Treatment of Fatigue and Neurobehavioral Function Related to Chemotherapy in Adult Cancer Patients — Completed